iShares US Pharmaceuticals ETF
111 hedge funds and large institutions have $441M invested in iShares US Pharmaceuticals ETF in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 10 closing their positions.
100% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 10
61% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 28
42% more capital invested
Capital invested by funds: $311M → $441M (+$130M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more funds holding
Funds holding: 102 → 111 (+9)
4.11% more ownership
Funds ownership: 112.03% → 116.14% (+4.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$51.2M |
| 2 |
Morgan Stanley
New York
|
+$17.5M |
| 3 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$8.98M |
| 4 |
LPL Financial
San Diego,
California
|
+$5.53M |
| 5 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
+$4.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.62M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.35M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$4.32M |
| 4 |
SFI
SPC Financial Inc
Rockville,
Maryland
|
-$1.65M |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.56M |
IHE Hedge Fund Activity: Q1 2015 in Review
111 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q1 2015, worth a combined $441M — up 42% from $311M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new IHE positions and 10 closed out — a net gain of 10 holders — while 45 added to existing stakes and 28 trimmed.
The largest buyer was Bank of Montreal, adding an estimated $51.2M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $6.62M sold.
- 111 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q1 2015, up from 102 in Q4 2014.
- Funds reported $441M of iShares US Pharmaceuticals ETF stock for Q1 2015, up 42% quarter-over-quarter.
- 20 funds opened new iShares US Pharmaceuticals ETF positions in Q1 2015 and 10 closed out, a net change of +10 holders.
- The largest iShares US Pharmaceuticals ETF buyer in Q1 2015 was Bank of Montreal, an estimated $51.2M added.
- The largest iShares US Pharmaceuticals ETF seller in Q1 2015 was Susquehanna International Group, an estimated $6.62M sold.
Based on aggregated 13F filings for Q1 2015.